Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Salmonella infection (mmu05132)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
5430435G
22Rik
KLA  ATP  ATP+KLA
 NM_145509 RIKEN cDNA 5430435G22 gene (5430435G22Rik), mRNA [NM_145509] KLA .11 .11 .22 .41 .66 1.09 .87
ATP 1.02 .96 1.19 .84 .89 .58 1.60
KLA/ATP .11 .11 .23 .28 .87 .62 1.51
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
AK032538
KLA  ATP  ATP+KLA
 AK032538 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430586B05 product:unclassifiable, full insert sequence [AK032538] KLA .97 .99 .99 .93 .97 .98 .97
ATP .99 .95 .99 .94 .98 1.05 1.00
KLA/ATP .93 1.02 .98 .98 1.05 .88 1.05
Arpc1a
KLA  ATP  ATP+KLA
 NM_019767 actin related protein 2/3 complex, subunit 1A (Arpc1a), mRNA [NM_019767] KLA .80 .78 .73 .79 .90 1.02 .97
ATP 1.01 1.07 .93 .86 .83 1.14 1.15
KLA/ATP .77 .74 .64 .64 .77 1.13 1.51
Arpc1b
KLA  ATP  ATP+KLA
 NM_023142 actin related protein 2/3 complex, subunit 1B (Arpc1b), mRNA [NM_023142] KLA .85 .86 .81 .83 .92 .93 1.03
ATP 1.03 .98 .86 .79 .84 .85 .91
KLA/ATP .88 .84 .83 .73 .71 .70 .63
Arpc2
KLA  ATP  ATP+KLA
 NM_029711 actin related protein 2/3 complex, subunit 2 (Arpc2), mRNA [NM_029711] KLA .88 .89 1.05 .92 1.18 1.31 1.21
ATP 1.20 1.18 .86 .94 .85 .48 .87
KLA/ATP 1.04 1.05 .78 .87 .70 .60 .92
Arpc3
KLA  ATP  ATP+KLA
 NM_019824 actin related protein 2/3 complex, subunit 3 (Arpc3), mRNA [NM_019824] KLA .93 .96 1.05 .95 1.07 1.09 .80
ATP 1.08 1.05 .95 .99 1.03 1.01 .97
KLA/ATP 1.00 1.02 .99 1.04 1.06 1.21 .99
Arpc4
KLA  ATP  ATP+KLA
 NM_026552 actin related protein 2/3 complex, subunit 4 (Arpc4), mRNA [NM_026552] KLA .75 .81 .83 .73 .94 1.12 1.12
ATP 1.09 1.34 .90 1.52 .98 .63 .89
KLA/ATP .92 .90 .58 1.10 .64 .69 .87
Arpc5
KLA  ATP  ATP+KLA
 NM_026369 actin related protein 2/3 complex, subunit 5 (Arpc5), mRNA [NM_026369] KLA 1.35 1.37 1.44 1.33 1.59 1.84 1.39
ATP .98 1.08 1.01 1.14 .97 .87 1.36
KLA/ATP 1.19 1.30 1.23 1.44 1.13 1.28 1.60
Arpc5l
KLA  ATP  ATP+KLA
 NM_028809 actin related protein 2/3 complex, subunit 5-like (Arpc5l), mRNA [NM_028809] KLA .59 .61 .60 .59 .61 .77 1.02
ATP .92 .92 .99 1.01 .79 .76 1.01
KLA/ATP .58 .60 .64 .59 .66 .71 .98
BC005774
KLA  ATP  ATP+KLA
 BC005774 cDNA clone MGC:12006 IMAGE:3602466, complete cds [BC005774] KLA .95 1.08 .93 1.05 .99 .98 .95
ATP 1.21 1.29 1.09 1.16 1.16 1.04 1.00
KLA/ATP .99 1.00 .92 1.02 1.00 .90 .91
Casp1
KLA  ATP  ATP+KLA
 NM_009807 caspase 1 (Casp1), mRNA [NM_009807] KLA 4.27 4.63 5.39 6.07 5.87 5.49 2.96
ATP .93 .87 1.01 .80 1.05 3.11 2.77
KLA/ATP 4.31 4.18 5.40 4.00 4.66 4.90 7.20
Ccl3
KLA  ATP  ATP+KLA
 NM_011337 chemokine (C-C motif) ligand 3 (Ccl3), mRNA [NM_011337] KLA 22.83 22.40 18.03 21.58 11.57 8.28 7.46
ATP 3.19 4.67 12.12 16.50 11.13 9.49 6.12
KLA/ATP 20.09 20.92 34.53 24.06 21.64 12.34 7.43
Ccl4
KLA  ATP  ATP+KLA
 NM_013652 chemokine (C-C motif) ligand 4 (Ccl4), mRNA [NM_013652] KLA 68.93 60.20 52.12 67.06 35.78 15.78 8.82
ATP 2.26 3.82 16.88 43.14 26.67 9.47 6.75
KLA/ATP 59.57 71.75 133.98 193.53 81.76 15.96 7.62
Cd14
KLA  ATP  ATP+KLA
 NM_009841 CD14 antigen (Cd14), mRNA [NM_009841] KLA 2.35 2.68 2.54 2.21 2.39 1.52 1.57
ATP 1.44 2.28 2.82 3.98 6.68 16.14 6.92
KLA/ATP 2.92 3.79 3.96 5.12 5.29 10.42 11.50
Cdc42
KLA  ATP  ATP+KLA
 NM_009861 cell division cycle 42 homolog (S. cerevisiae) (Cdc42), mRNA [NM_009861] KLA 1.04 1.01 1.02 1.04 1.12 1.21 1.12
ATP 1.07 1.10 1.04 1.06 1.02 .95 1.14
KLA/ATP .94 1.04 1.01 .97 .95 1.02 1.25
Csf2
KLA  ATP  ATP+KLA
 NM_009969 colony stimulating factor 2 (granulocyte-macrophage) (Csf2), mRNA [NM_009969] KLA 1.44 1.53 1.38 1.37 1.15 1.21 1.14
ATP 1.01 1.02 1.85 9.73 2.64 1.90 1.14
KLA/ATP 1.49 1.84 2.14 2.80 1.67 1.36 1.35
Cxcl1
KLA  ATP  ATP+KLA
 NM_008176 chemokine (C-X-C motif) ligand 1 (Cxcl1), mRNA [NM_008176] KLA 36.87 30.25 15.74 8.84 5.41 3.01 5.84
ATP 2.77 8.26 128.38 289.44 262.38 218.83 26.91
KLA/ATP 41.06 56.76 91.82 164.83 91.44 77.89 79.05
Cxcl2
KLA  ATP  ATP+KLA
 NM_009140 chemokine (C-X-C motif) ligand 2 (Cxcl2), mRNA [NM_009140] KLA 20.11 17.63 13.50 7.78 9.14 3.98 10.85
ATP 10.96 27.84 145.37 396.18 303.88 165.35 21.04
KLA/ATP 33.28 74.00 189.99 348.56 93.84 68.75 64.87
Cxcl3
KLA  ATP  ATP+KLA
 NM_203320 chemokine (C-X-C motif) ligand 3 (Cxcl3), mRNA [NM_203320] KLA 35.82 43.91 31.09 16.74 3.98 2.27 2.93
ATP 1.13 1.23 3.43 12.43 126.40 310.60 215.03
KLA/ATP 36.32 44.70 46.93 50.61 18.91 95.89 296.64
Dync1h1
KLA  ATP  ATP+KLA
 NM_030238 dynein cytoplasmic 1 heavy chain 1 (Dync1h1), mRNA [NM_030238] KLA 1.78 1.64 2.10 1.64 1.91 1.55 1.26
ATP 1.16 1.06 1.00 .56 1.07 1.46 1.19
KLA/ATP 1.98 1.98 1.86 1.05 1.64 1.66 1.75
Dync1h1
KLA  ATP  ATP+KLA
 Z83808 gb|M.musculus mRNA for cytoplasmic dynein heavy chain (partial, ID mdhc10). [Z83808] KLA 1.48 1.24 1.23 1.53 1.45 1.52 1.26
ATP 1.13 1.04 .97 1.04 1.10 1.31 1.09
KLA/ATP 1.55 1.62 1.64 1.29 1.30 1.33 1.35
Dync1i1
KLA  ATP  ATP+KLA
 NM_010063 dynein cytoplasmic 1 intermediate chain 1 (Dync1i1), mRNA [NM_010063] KLA .81 .84 .79 .81 .84 .85 .93
ATP 1.05 1.00 .92 .96 .85 .82 .91
KLA/ATP .88 .84 .86 .79 .80 .81 .97
Dync1i2
KLA  ATP  ATP+KLA
 NM_010064 dynein cytoplasmic 1 intermediate chain 2 (Dync1i2), mRNA [NM_010064] KLA 2.07 2.25 2.75 2.53 2.86 2.50 1.24
ATP 1.03 1.12 .99 1.05 .88 .92 1.60
KLA/ATP 2.16 2.32 2.03 2.39 1.81 1.77 2.27
Dync1li1
KLA  ATP  ATP+KLA
 NM_146229 dynein cytoplasmic 1 light intermediate chain 1 (Dync1li1), mRNA [NM_146229] KLA 1.59 1.52 1.69 1.43 1.36 1.25 1.27
ATP 1.23 1.44 1.25 1.78 1.97 1.33 1.27
KLA/ATP 1.72 1.86 1.35 2.03 1.57 1.58 1.52
Dync1li2
KLA  ATP  ATP+KLA
 AK140743 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130001C04 product:Dynein light intermediate chain 2, cytosolic (LIC53 [AK140743] KLA .51 .51 .43 .50 .70 .76 .89
ATP .98 .82 .67 .45 .62 .68 .71
KLA/ATP .49 .46 .36 .32 .55 .48 .51
Dync1li2
KLA  ATP  ATP+KLA
 NM_001013380 dynein, cytoplasmic 1 light intermediate chain 2 (Dync1li2), mRNA [NM_001013380] KLA 1.11 1.12 1.12 1.10 1.28 1.37 1.41
ATP 1.00 1.04 .93 .97 1.06 1.52 1.75
KLA/ATP 1.12 1.18 1.00 1.10 1.03 1.32 2.18
Dync2h1
KLA  ATP  ATP+KLA
 NM_029851 dynein cytoplasmic 2 heavy chain 1 (Dync2h1), mRNA [NM_029851] KLA 1.12 1.12 1.20 1.24 1.30 1.32 .94
ATP 1.04 .96 .89 .71 .71 1.08 .92
KLA/ATP 1.09 1.10 1.09 .89 .94 1.34 1.36
Flna
KLA  ATP  ATP+KLA
 AK044856 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130008E07 product:hypothetical Calponin homology (CH) domain containing protein, full insert sequence. [AK044856] KLA .95 .95 1.00 .99 1.02 1.10 1.00
ATP .93 .94 1.02 1.08 1.04 1.01 .99
KLA/ATP 1.02 .98 .99 .98 1.02 1.08 1.02
Flna
KLA  ATP  ATP+KLA
 NM_010227 filamin, alpha (Flna), mRNA [NM_010227] KLA .90 .91 .92 .83 1.03 1.12 .82
ATP 1.02 1.06 .77 .69 .58 .69 .72
KLA/ATP .97 .90 .69 .66 .49 .59 .83
Flnb
KLA  ATP  ATP+KLA
 AK050046 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730006K15 product:filamin, beta, full insert sequence. [AK050046] KLA 5.58 4.67 5.09 3.71 3.12 1.55 1.22
ATP .97 1.04 1.40 1.56 2.09 1.87 1.06
KLA/ATP 6.20 5.77 5.48 4.31 2.53 2.35 1.37
Flnb
KLA  ATP  ATP+KLA
 NM_134080 filamin, beta (Flnb), mRNA [NM_134080] KLA 8.86 8.95 10.89 9.75 10.94 7.28 1.54
ATP 1.03 1.08 1.17 1.39 1.82 2.72 1.01
KLA/ATP 8.89 10.37 11.36 10.83 7.90 5.59 3.36
Flnc
KLA  ATP  ATP+KLA
 AK051985 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230030L22 product:weakly similar to CGABP260 ACTIN-BINDING DOMAIN (FRAGMENT) [Gallus gallus], full insert sequence. [AK051985] KLA .97 1.04 1.01 1.03 1.01 1.05 1.06
ATP 1.02 1.04 1.00 1.02 1.02 1.10 1.06
KLA/ATP 1.00 1.00 .98 1.07 1.03 1.07 1.04
Flnc
KLA  ATP  ATP+KLA
 NM_001081185 filamin C, gamma (actin binding protein 280) (Flnc), mRNA [NM_001081185] KLA .95 1.00 1.02 1.00 .95 .98 1.05
ATP 1.02 1.01 1.11 1.37 1.04 1.04 1.13
KLA/ATP .99 1.02 .93 1.00 .90 .99 1.03
Fos
KLA  ATP  ATP+KLA
 NM_010234 FBJ osteosarcoma oncogene (Fos), mRNA [NM_010234] KLA .42 .33 .64 .61 .71 .85 .71
ATP 3.48 5.46 23.78 25.22 1.71 2.36 1.50
KLA/ATP .90 1.74 5.97 8.62 1.28 2.42 4.52
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Il18
KLA  ATP  ATP+KLA
 NM_008360 interleukin 18 (Il18), mRNA [NM_008360] KLA 12.14 11.96 12.28 12.96 12.23 7.84 2.40
ATP 1.06 .96 1.13 1.04 .92 1.67 2.29
KLA/ATP 11.55 11.63 13.03 9.98 9.08 6.50 6.72
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
Klc1
KLA  ATP  ATP+KLA
 NM_008450 kinesin light chain 1 (Klc1), transcript variant a, mRNA [NM_008450] KLA 1.12 1.08 1.08 1.11 1.12 1.30 1.16
ATP .88 .89 .71 .60 .68 .80 1.96
KLA/ATP 1.05 1.11 .95 .75 .72 .69 1.68
Klc2
KLA  ATP  ATP+KLA
 NM_008451 kinesin light chain 2 (Klc2), mRNA [NM_008451] KLA 1.12 1.12 1.16 1.18 1.10 1.23 1.53
ATP 1.01 1.11 .95 1.04 .89 1.19 1.26
KLA/ATP 1.19 1.17 1.03 1.10 .93 1.11 1.32
Klc3
KLA  ATP  ATP+KLA
 NM_146182 kinesin light chain 3 (Klc3), mRNA [NM_146182] KLA .92 .90 .88 .90 .89 .81 .67
ATP 1.01 .96 .96 .86 .79 .98 .94
KLA/ATP .90 1.03 .96 .84 .85 .84 .75
Klc4
KLA  ATP  ATP+KLA
 NM_029091 kinesin light chain 4 (Klc4), mRNA [NM_029091] KLA .27 .26 .19 .17 .19 .38 .50
ATP .99 .99 .59 .64 .39 .31 1.18
KLA/ATP .29 .24 .16 .22 .21 .29 .81
Lbp
KLA  ATP  ATP+KLA
 NM_008489 lipopolysaccharide binding protein (Lbp), mRNA [NM_008489] KLA 1.01 1.01 .94 1.02 1.03 1.06 1.00
ATP 1.00 .99 .96 1.03 .91 .89 .84
KLA/ATP .98 .96 1.01 .93 1.00 .95 .83
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mm.11689
4
KLA  ATP  ATP+KLA
 124248589 Unknown KLA .85 .82 .79 .95 .77 .84 .58
ATP 1.04 1.03 .99 .93 .82 .79 .78
KLA/ATP .92 .86 .85 .79 .78 .79 .64
Mm.18143
0
KLA  ATP  ATP+KLA
 134288916 Unknown KLA 1.92 1.66 1.89 1.74 1.97 1.74 1.15
ATP 1.14 .96 .93 .44 .91 1.60 1.19
KLA/ATP 1.77 1.70 2.16 .89 1.58 1.61 1.64
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.27959
9
KLA  ATP  ATP+KLA
 142366781 Unknown KLA .27 .24 .22 .19 .19 .37 .47
ATP .83 .70 .69 .52 .39 .35 .98
KLA/ATP .24 .22 .22 .19 .25 .34 .64
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.31188
4
KLA  ATP  ATP+KLA
 146198620 Unknown KLA .69 .70 .77 1.02 1.29 2.04 1.80
ATP .91 .82 .91 .83 1.09 2.72 1.14
KLA/ATP .65 .57 .81 .73 .88 2.07 3.86
Mm.37161
0
KLA  ATP  ATP+KLA
 118130576 Unknown KLA .76 .74 .66 .81 .74 1.00 .92
ATP .95 .85 1.03 .71 .79 1.32 1.10
KLA/ATP .69 .70 .67 .53 .84 1.50 1.48
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Myd88
KLA  ATP  ATP+KLA
 NM_010851 myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] KLA 3.35 3.51 3.91 4.13 4.13 3.62 2.53
ATP .99 .96 .79 .75 .93 2.15 1.60
KLA/ATP 3.37 3.52 3.52 3.48 2.81 3.03 3.33
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nlrc4
KLA  ATP  ATP+KLA
 NM_001033367 NLR family, CARD domain containing 4 (Nlrc4), mRNA [NM_001033367] KLA .81 .77 .85 .98 1.35 1.96 1.86
ATP 1.09 .92 .83 .90 1.19 1.63 1.12
KLA/ATP .83 .72 .90 .94 .92 1.64 3.46
Nos2
KLA  ATP  ATP+KLA
 NM_010927 nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927] KLA 13.50 16.36 25.65 23.25 24.78 15.99 6.48
ATP 1.03 1.03 1.48 1.66 1.65 5.55 1.70
KLA/ATP 16.01 17.41 19.06 25.50 20.84 29.92 29.80
Pfn1
KLA  ATP  ATP+KLA
 NM_011072 profilin 1 (Pfn1), mRNA [NM_011072] KLA .83 1.00 .95 .82 .96 1.18 1.41
ATP 1.21 1.60 .75 1.78 1.08 .72 1.09
KLA/ATP 1.27 1.22 .45 1.61 .70 1.00 1.18
Pfn2
KLA  ATP  ATP+KLA
 NM_019410 profilin 2 (Pfn2), mRNA [NM_019410] KLA .92 .86 .85 .87 .87 .83 1.02
ATP 1.02 1.06 .99 .95 .83 .96 .90
KLA/ATP .88 .89 .92 .83 .76 .81 .98
Pfn3
KLA  ATP  ATP+KLA
 NM_029303 profilin 3 (Pfn3), mRNA [NM_029303] KLA 1.02 .94 .93 .93 .98 .98 .99
ATP 1.06 .95 1.05 .92 .98 .91 1.04
KLA/ATP 1.04 .92 1.04 .95 1.03 .92 1.05
Pfn4
KLA  ATP  ATP+KLA
 NM_028376 profilin family, member 4 (Pfn4), mRNA [NM_028376] KLA 1.03 1.02 .94 .92 .94 .91 .98
ATP 1.05 1.03 1.05 .93 .97 1.00 .94
KLA/ATP 1.05 .95 .94 .89 .90 .88 .90
Pkn1
KLA  ATP  ATP+KLA
 NM_177262 protein kinase N1 (Pkn1), mRNA [NM_177262] KLA 1.00 1.05 1.21 1.17 1.81 2.23 1.45
ATP 1.04 1.08 .91 1.07 .93 1.41 2.42
KLA/ATP 1.09 1.06 .93 1.08 .91 1.73 3.64
Pkn2
KLA  ATP  ATP+KLA
 AK140746 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130001L23 product:protein kinase N2, full insert sequence [AK140746] KLA 2.11 2.12 2.30 1.86 1.65 1.52 1.45
ATP 1.03 1.09 .93 .96 1.69 1.26 1.10
KLA/ATP 2.12 2.03 1.58 1.65 1.92 1.41 1.37
Pkn2
KLA  ATP  ATP+KLA
 NM_178654 protein kinase N2 (Pkn2), mRNA [NM_178654] KLA 1.99 2.05 2.24 2.09 1.67 1.69 1.57
ATP 1.05 1.11 1.29 1.36 2.32 2.68 1.55
KLA/ATP 2.03 2.15 2.31 2.32 3.12 2.89 2.30
Pkn3
KLA  ATP  ATP+KLA
 AK154801 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630107C11 product:protein kinase N3, full insert sequence [AK154801] KLA 2.16 2.25 2.92 2.78 3.14 3.90 2.74
ATP 1.08 1.03 1.18 1.20 1.18 1.59 3.46
KLA/ATP 2.36 2.41 2.70 2.63 2.44 3.39 7.83
Pkn3
KLA  ATP  ATP+KLA
 NM_153805 protein kinase N3 (Pkn3), mRNA [NM_153805] KLA .82 .78 .76 .76 .73 .73 .68
ATP .96 1.06 1.04 1.01 .81 1.03 .78
KLA/ATP .84 .77 .81 .77 .76 .89 .76
Plekhm2
KLA  ATP  ATP+KLA
 XM_980218 gb|PREDICTED: Mus musculus pleckstrin homology domain containing, family M (with RUN domain) member 2 (Plekhm2), mRNA [XM_980218] KLA .57 .57 .70 .77 1.03 1.22 1.24
ATP 1.13 1.15 .87 1.08 1.44 1.01 1.62
KLA/ATP .64 .63 .55 .73 1.57 1.62 2.22
Pycard
KLA  ATP  ATP+KLA
 NM_023258 PYD and CARD domain containing (Pycard), mRNA [NM_023258] KLA 1.48 1.44 1.62 1.81 1.80 1.69 .94
ATP .89 .88 1.00 .84 .52 .30 .62
KLA/ATP 1.32 1.34 1.65 1.38 1.14 .50 .41
Rab7
KLA  ATP  ATP+KLA
 BI654107 gb|603280186F1 NCI_CGAP_Mam4 Mus musculus cDNA clone IMAGE:5310477 5, mRNA sequence [BI654107] KLA 1.08 1.15 1.33 1.10 1.13 1.26 1.24
ATP .99 1.11 1.08 1.39 1.49 1.69 2.44
KLA/ATP 1.19 1.17 1.12 1.51 1.30 1.77 2.20
Rab7
KLA  ATP  ATP+KLA
 DV064670 gb|NEONATAL_23_D05.x1 FH NEONATAL Mus musculus cDNA clone NEONATAL_23_D05 similar to RAB7 member RAS oncogene family, mRNA sequence [DV064670] KLA 1.01 1.03 1.05 .90 .94 .97 1.09
ATP 1.05 1.16 1.00 1.26 1.36 1.36 1.97
KLA/ATP 1.16 1.08 .77 1.23 1.12 1.41 1.50
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rhog
KLA  ATP  ATP+KLA
 NM_019566 ras homolog gene family, member G (Rhog), mRNA [NM_019566] KLA 1.57 1.55 1.66 1.83 2.33 1.91 2.00
ATP 1.26 1.37 .78 1.26 1.18 1.68 1.74
KLA/ATP 1.96 2.13 1.20 1.98 1.11 1.62 3.39
Rilp
KLA  ATP  ATP+KLA
 NM_001029938 Rab interacting lysosomal protein (Rilp), mRNA [NM_001029938] KLA .76 .77 .73 .70 .65 .66 .65
ATP 1.10 1.03 .93 1.12 .89 .78 .94
KLA/ATP .85 .79 .93 .83 .75 .65 .72
Rock1
KLA  ATP  ATP+KLA
 NM_009071 Rho-associated coiled-coil containing protein kinase 1 (Rock1), mRNA [NM_009071] KLA 2.40 2.48 2.37 3.07 1.94 1.42 1.21
ATP .95 .92 .87 .70 1.13 1.74 .98
KLA/ATP 2.27 2.35 2.56 1.60 1.65 1.56 1.23
Rock2
KLA  ATP  ATP+KLA
 NM_009072 Rho-associated coiled-coil containing protein kinase 2 (Rock2), mRNA [NM_009072] KLA .99 .92 .83 .87 .73 .74 1.04
ATP 1.07 1.31 1.16 1.02 1.02 1.03 .88
KLA/ATP 1.00 1.07 .93 .85 .69 .63 .81
Tjp1
KLA  ATP  ATP+KLA
 NM_009386 tight junction protein 1 (Tjp1), mRNA [NM_009386] KLA 1.00 1.03 1.07 1.00 1.03 1.03 1.09
ATP 1.01 .98 1.06 1.00 1.00 1.05 1.04
KLA/ATP .99 1.04 1.06 1.08 1.10 1.21 1.11
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Tlr5
KLA  ATP  ATP+KLA
 AF186107 toll-like receptor 5 (Tlr5) mRNA, complete cds [AF186107] KLA .78 .75 .84 .78 .72 .74 .43
ATP .98 1.07 .99 .95 .79 .66 .61
KLA/ATP .79 .81 .77 .73 .73 .67 .50
Was
KLA  ATP  ATP+KLA
 NM_009515 Wiskott-Aldrich syndrome homolog (human) (Was), mRNA [NM_009515] KLA .66 .67 .64 .65 .88 1.08 1.09
ATP 1.08 1.11 .87 1.23 .77 .51 .90
KLA/ATP .76 .70 .44 .83 .49 .61 .91
Wasf1
KLA  ATP  ATP+KLA
 NM_031877 WASP family 1 (Wasf1), mRNA [NM_031877] KLA .75 .69 .77 .81 .69 .66 .54
ATP 1.01 .97 .93 .98 .70 .66 .97
KLA/ATP .75 .73 .80 .79 .73 .67 .56
Wasf2
KLA  ATP  ATP+KLA
 AK150140 bone marrow macrophage cDNA, RIKEN full-length enriched library, clone:G530136J12 product:WAS protein family, member 2, full insert sequence [AK150140] KLA .58 .52 .52 .83 1.06 1.17 .91
ATP .97 .89 .93 .57 .72 .72 .86
KLA/ATP .55 .45 .56 .36 .45 .65 1.08
Wasf2
KLA  ATP  ATP+KLA
 NM_153423 WAS protein family, member 2 (Wasf2), mRNA [NM_153423] KLA .67 .75 .66 1.01 1.31 1.28 1.19
ATP 1.05 1.10 .82 .81 .82 .68 .92
KLA/ATP .75 .76 .73 .57 .61 .77 1.16
Wasl
KLA  ATP  ATP+KLA
 NM_028459 Wiskott-Aldrich syndrome-like (human) (Wasl), mRNA [NM_028459] KLA .88 .89 .96 .85 .97 1.08 1.14
ATP 1.08 .99 .71 .76 1.71 .91 .99
KLA/ATP .96 .84 .72 .84 1.51 .91 1.24